NOVO NORDISK A S (NVO)
Clinical trial NCT07112339 updates: 1. completion date: 2028-08-31 → 2028-03-23 2. primary completion date: 2026-08-04 → 2028-03-23
Clinical trial NCT07112339 updates: 1. completion date: 2028-08-31 → 2028-03-23 2. primary completion date: 2026-08-04 → 2028-03-23
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical